Induction of tolerance and immunity by redirected B cell-specific cytolytic T lymphocytes.

about

Induction of tolerance and immunity by redirected B cell-specific cytolytic T lymphocytes.

Item

http://www.wikidata.org/entity/Q45871875

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Induction of tolerance and imm ...... cific cytolytic T lymphocytes.

@en

Induction of tolerance and imm ...... cific cytolytic T lymphocytes.

@nl

type

Item

label

Induction of tolerance and imm ...... cific cytolytic T lymphocytes.

@en

Induction of tolerance and imm ...... cific cytolytic T lymphocytes.

@nl

prefLabel

Induction of tolerance and imm ...... cific cytolytic T lymphocytes.

@en

Induction of tolerance and imm ...... cific cytolytic T lymphocytes.

@nl

P1476

Induction of tolerance and immunity by redirected B cell-specific cytolytic T lymphocytes

@en

P2093

C T Duthoit

http://www.w3.org/2001/XMLSchema#string

P Nguyen

http://www.w3.org/2001/XMLSchema#string

P2860

Adoptive immunotherapy for cancer: building on success

Gene therapy approaches to HIV-infection: immunological strategies: use of T bodies and universal receptors to redirect cytolytic T-cells.

Development and application of receptor-modified T lymphocytes for adoptive immunotherapy.

The allogeneic response and tumor immunity.

Migration of naive, effector and memory T cells: implications for the regulation of immune responses.

Targeting tumours with genetically enhanced T lymphocytes.

Chimeric T-cell receptors for the targeting of cancer cells.

A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer.

Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain.

Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes.

P2888

sj.gt.3303045

P304

1739-1749

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.GT.3303045

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Terrence L Geiger

P577

2007-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5916100

http://www.w3.org/2001/XMLSchema#string

P6179

1045662206

http://www.w3.org/2001/XMLSchema#string

P698

17928872

http://www.w3.org/2001/XMLSchema#string